BM

Balakrishnan Murali

Active Director Director DIN 10219803
DIN 10219803 First appointment Jul 2023 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2023
Shareholding value •••• Premium profile

About Balakrishnan Murali

Data last updated:

Balakrishnan Murali is a Director at Kanthariplus Suraksha Pharma Private Limited (since 2023). The company operates in Healthcare. Kanthariplus Suraksha Pharma Private Limited reported revenue of ₹11.38 Cr (FY 2025).

DIN 10219803
Primary Designation Director
Industry Healthcare
First Appointment 10 Jul 2023
Oldest Company Age 6 yrs
Largest company Kanthariplus Suraksha Pharma Private Limited · ₹11.38 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director10 Jul 20232019₹11.38 Cr (FY 2025)Active

Board colleagues of Balakrishnan Murali

Directorship timeline

Open interactive timeline →
Kanthariplus Suraksha Pharma Private Limited
Premium access

Shareholding and investment profile for Balakrishnan Murali

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Balakrishnan Murali

Balakrishnan Murali currently holds 1 directorship: Kanthariplus Suraksha Pharma Private Limited (Director, since 10 Jul 2023, revenue ₹11.38 Cr (FY 2025)).

Balakrishnan Murali was first appointed on 10 Jul 2023 as Director at Kanthariplus Suraksha Pharma Private Limited.

The current boards of Balakrishnan Murali's companies include Krishnamallan Gopinathamallan (Kanthariplus Suraksha Pharma Private Limited), Vijayakumari (Kanthariplus Suraksha Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available